Michael Mano, SVP, General Counsel&Secretary at Karyopharm Therapeutics Inc. (KPTI), sold 6,878 shares at $3.03 ($21K) on 2023-03-01, disclosed to the SEC on 2023-03-02.
Open-market sale of $21k KPTI by SVP, General Counsel&Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| KPTI | SELL | 2025-09-16 | $2K | — | Filing → |
| KPTI | SELL | 2025-03-06 | $18K | — | Filing → |
| KPTI | SELL | 2024-09-05 | $3K | — | Filing → |